We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

286 hedge funds and large institutions have $2.79B invested in Amedisys in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 115 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more funds holding in top 10

Funds holding in top 10: 211 (+9)

2% more capital invested

Capital invested by funds: $2.74B → $2.79B (+$55.1M)

1.32% less ownership

Funds ownership: 91.96%90.64% (-1.3%)

5% less funds holding

Funds holding: 301286 (-15)

22% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 115

26% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 53

93% less call options, than puts

Call options by funds: $5.97M | Put options by funds: $81.6M

Holders
286
Holders Change
-15
Holders Change %
-4.98%
% of All Funds
4.54%
Holding in Top 10
11
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+450%
% of All Funds
0.17%
New
39
Increased
90
Reduced
115
Closed
53
Calls
$5.97M
Puts
$81.6M
Net Calls
-$75.6M
Net Calls Change
-$69.6M
Name Holding Trade Value Shares
Change
Change in
Stake
BPCE
151
Bank Pictet & Cie (Europe)
Germany
$980K
SAM
152
Silphium Asset Management
United Kingdom
$893K +$884K +9,563 New
Squarepoint
153
Squarepoint
New York
$878K -$1.68M -18,217 -66%
BPC
154
Banque Pictet & Cie
Switzerland
$877K
ASRS
155
Arizona State Retirement System
Arizona
$867K +$13K +141 +2%
LSERS
156
Louisiana State Employees Retirement System
Louisiana
$859K -$27.7K -300 -3%
OPERF
157
Oregon Public Employees Retirement Fund
Oregon
$856K -$27.7K -300 -3%
LCM
158
Legato Capital Management
California
$839K -$32.5K -352 -4%
GC
159
Guggenheim Capital
Illinois
$806K +$22.4K +242 +3%
TAL
160
TIG Advisors LLC
New York
$789K -$1.76M -19,100 -69%
Thrivent Financial for Lutherans
161
Thrivent Financial for Lutherans
Minnesota
$763K -$22.2K -240 -3%
FSI
162
Flow State Investments
Illinois
$747K +$739K +8,000 New
Victory Capital Management
163
Victory Capital Management
Texas
$732K -$22.5K -243 -3%
SOMRS
164
State of Michigan Retirement System
Michigan
$726K -$27.7K -300 -4%
TCM
165
Teza Capital Management
Illinois
$702K +$695K +7,517 New
Cetera Investment Advisers
166
Cetera Investment Advisers
Illinois
$692K +$149K +1,611 +28%
AIP
167
Ameritas Investment Partners
Nebraska
$684K -$75.6K -818 -10%
NMIMC
168
Northwestern Mutual Investment Management Company
Wisconsin
$676K -$370 -4 -0.1%
PCM
169
Penn Capital Management
Pennsylvania
$664K +$431K +4,664 +191%
Nomura Holdings
170
Nomura Holdings
Japan
$654K +$92.4K +1,000 +17%
AQR Capital Management
171
AQR Capital Management
Connecticut
$636K +$175K +1,897 +39%
PNC Financial Services Group
172
PNC Financial Services Group
Pennsylvania
$623K -$147K -1,593 -19%
COPPSERS
173
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$617K -$845K -9,143 -58%
NMERB
174
New Mexico Educational Retirement Board
New Mexico
$616K
ETC
175
Exchange Traded Concepts
Oklahoma
$609K +$603K +6,522 New

AMED Hedge Fund Activity: Q3 2023 in Review

286 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2023, worth a combined $2.79B — up 2% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of AMED and 39 opened new positions — a net loss of 14 holders — while 115 trimmed existing stakes and 90 added.

The largest buyer was Pentwater Capital Management, adding an estimated $74.6M. The largest seller was Deerfield Management, exiting entirely with an estimated $164M sold.

  • 286 institutional investors held Amedisys (AMED) as of Q3 2023, down from 301 in Q2 2023.
  • Funds reported $2.79B of Amedisys stock for Q3 2023, up 2% quarter-over-quarter.
  • 39 funds opened new Amedisys positions in Q3 2023 and 53 closed out, a net change of -14 holders.
  • The largest Amedisys buyer in Q3 2023 was Pentwater Capital Management, an estimated $74.6M added.
  • The largest Amedisys seller in Q3 2023 was Deerfield Management, an estimated $164M sold.

Based on aggregated 13F filings for Q3 2023.